폴리글리콜산 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Polyglycolic Acid Market

The future of the global polyglycolic acid market looks promising with opportunities in the oil & gas, medical, and packing markets. The global polyglycolic acid market is expected to reach an estimated $15.5 billion by 2035 from $6.9 billion in 2027 with a CAGR of 9.5% from 2027 to 2035. The major drivers for this market are the increasing use in absorbable surgical sutures, the rising demand for biodegradable packaging materials, and the growing application in drug delivery systems.

• Lucintel forecasts that, within the type category, medical grade is expected to witness higher growth over the forecast period due to high biocompatibility and biodegradability make them suitable for medical applications.
• Within the application category, medical is expected to witness the highest growth over the forecast period due to the increased use of biodegradable polymers in surgical and medical devices.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to medical device manufacturing and the healthcare infrastructure in the region are actively growing.

Emerging Trends in Polyglycolic Acid Market

During the period 2025 to 2027, the polyglycolic acid market is expected to shift from specialist medical applications to broad market demand driven by performance considerations. Polyglycolic acid has several advantages over other materials, and is the foundation of a number of emerging technologies including resorbable sutures, tissue engineering, controlled drug delivery, and even "green" packaging. Lucintel anticipates that investment will be driven by applications with predictable degradation, biocompatibility, and manufacturability.

• Sustainability: Polyglycolic acid continues to be one of the most significant materials for high-barrier, compostable packaging as it has been the focus of packaging developers in 2025, and continues to garner interest due to European policy pushing for more sustainable formats of packaging. Regulation and brand commitments may lead to a positive impact on the adoption of polyglycolic acid and packaging in the next three to five years, provided that a sustainable disposal infrastructure is in place.
• Medical Specialization: Using absorption and sustainable degradation allows polyglycolic acid to support medical specialization. Hospital and device company focus beyond standard sutures include absorbable meshes, clips, and drug-delivery systems. The global surgical volume is over 300 million, and the market will benefit from products with reduced need for follow up procedures and controlled hydrolysis.
• Advanced Manufacturing: Control of molecular weight and degradation profile coupled with precision extrusion is expected to increase in the period 2025 to 2027. Melt processing and additive manufacturing will reduce waste and help translate laboratory based research into production.
• Smart Biomaterials: The combination of polyglycolic acid with PLA, and hydroxyapatite and bioactive coatings has gained significant interest for advanced manufacturing, and research in 2025 continues to support localized drug delivery especially for bone therapy. The demand for these materials will grow outside of the resin supply and coating as competition for application-based formulations of biomaterials will increase.
• Regional Supply Diversification: New capacity planning in Asia and North America has increased reliance on multisource supply chains, while medical device customers are seeking dual qualified suppliers after recent disruptions in supply chain logistics. Over the next five years, qualification criteria and strategic inventory holding will tend to favor suppliers that can offer local technical support and a consistent logistical supply.

The polyglycolic acid market is expected to grow by serving a broader range of higher-margin medical products rather than growing by total volume. A second growth avenue may be sustainability, but there are constraints, including certification, cost of processing, and the end-of-life system. By commanding purity and control of the degradation rate of the polymer and also developing applications, suppliers can achieve higher margins. Buyers will require validated performance, evidence of regional supply, and evidence of supply chain sustainability.

Recent Developments in the Polyglycolic Acid Market

Polyglycolic acid market activity is growing. Polyglycolic acid is used in medical devices, absorption, controlled drug release, and barrier film applications and attracts capacity spending. Lucintel predicts an explosion of competition from 2025 to 2027, while qualification cycles are still slowing commercialization in the packaging and high-performance applications.

• Expanding Medical Device Portfolio: In February 2025, Corza Medical added absorbable surgical devices using PGA to its product offering, creating a demand for surgical suture products and establishing the medical device industry as the market's principal customer during the next 3 to 5 years.
• Domestic Manufacturing Investment: Chinese manufacturers had a production capacity increase targeting specialty biodegradable polymers in March 2025. This increase was greater than 10,000 tons. More domestic supply will create price competition for medical and converting packaging supplies.
• Advanced Packaging: In April 2025, research teams published results showing that oxygen permeation of PGA barrier films can be less than 1 cc/Ms and thus can be thinner than current structures. However, food contact approval would be a large barrier to market entrance.
• Integration of Drug Delivery: During May 2025, there were several academic-industry partnerships that reported PGA microspheres. This would allow for significant drug loadings of up to 20% weight, which could support new business in drug delivery beyond sutures. This could be a reality if companies are able to sustain a stable supply of PGA to the marketplace.
• Regulatory and Sustainability Push: In June 2025, European policy consultations ramped up scrutiny of non-recyclable multilayer packaging and disclosures on the material used in medical devices. PGA is benefiting from the growing trend of biodegradable packaging, but the cost of certification will be passed on to consumers, and with many suppliers able to document the feedstock, degradation and end-of-life performance, the certifications will likely not be sought after.

The shift toward engineered applications requiring degradation, is moving the market beyond the base of surgical materials. The demand for medical applications should remain stable and predictable, while the packaging market is largely dependent on certification and converter economics. Companies with integrated polymerization and molecular weight control to better serve application testing will gain market share. Smaller suppliers will see increased price competition from Asian suppliers, although more specialized grades will continue to have favorable prices through 2027.

Strategic Growth Opportunities in the Polyglycolic Acid Market

From 2024 to 2026, the demand for polyglycolic acid (PGA) will shift away from niche resorbable sutures and toward engineered degradation, barrier films and downhole applications. Expansion within the regulatory environment, meet circular economy goals, and enhance oilfield efficiencies are growing attractive opportunities. Lucintel is not considering the opportunity in terms of capacity, but in terms of the need for application proof.

• Advanced Medical Devices: PGA possesses the attributes for use in absorbable meshes, drug-delivery systems, and tissue-repair components. In February 2025, the FDA published approximately 20 classifications for absorbable sutures and other medical devices. For the next few years, medical device manufacturers will be more likely to select validated polymers that promote controlled healing and reduce the number of post-procedure visits.
• Oil and Gas Recovery: PGA's degradability makes it well suited for temporary plugs in hydraulic fracturing and other downhole applications. Due to its rising complexity and production costs, companies will be more interested in plug and abandonment technologies that reduce the number of costly interventions. In April 2025, U.S. crude oil production exceeded 13 million barrels per day.
• High Barrier Packaging: The use of multilayer PGA films for food and pharmaceutical packaging improves barrier properties. In January 2025, the EU Packaging and Packaging Waste Regulation established a 2030 goal for improvements in packaging recyclability. This will create a more attractive market for high barrier layers due to the balance of increased shelf life and decreased cost of goods sold.
• Sustainable Materials: PGA can be converted to a biodegradable film when controlled conditions of conversion and disposal are met. In March 2025, the European Bioplastics Association predicted an installation of approximately 5.7 million tonnes of bioplastics capacity by 2029. Broad demand will be achieved outside of medical applications through qualified conversion partnerships.
• Customized Manufacturing: Contract manufacturers customize molecular weight and fiber geometry and control degradation rates for specialized applications. By May 2025, additive-manufacturing systems for printing parts below 100 microns could be available on a commercial basis. Application specific formulations will allow for greater margins and shorter customer qualification.

Over the next five years, growth for polyglycolic acid will be more tied to qualification than to volume. Medical devices will continue to be the core market, but controlled degradation and packaging that is suited to gas-field separation will guide demand growth. Suppliers who have regulatory approval, local manufacturing, and application engineering will get a larger share of the market. For now, cost is the major factor, especially in price sensitive markets outside of healthcare.

Polyglycolic Acid Market Drivers and Challenges

The market for polyglycolic acid is projected to grow due to technological advancements, economic conditions, sustainability, and regulation. The demand will increase in the medical, packaging, and industrial sectors. However, the price and the performance of the material will still be a consideration. According to Lucintel, the major drivers will be the level of innovation, whether or not the material is biodegradable, the extent to which the material is adopted in the health care sector, and the supply chain and compliance issues.

These factors influence growth of the polyglycolic acid market:

• Growth in medical devices, e.g., polyglycolic acid is used in absorbable sutures, tissue scaffolds, drug delivery systems, surgical implants, etc., due to their biocompatibility. The health care industry and the spending on minimally invasive surgeries continued to grow in 2025. For the next 3 to 5 years, there will be a consistent demand for medical grade polyglycolic acid due to an aging population, increased surgeries, and research and development for advanced regenerative therapeutic and medical products.
• Use of Biodegradable Packaging: Many companies are now evaluating biodegradable polymers to create films, coatings, and specialty packaging. In February 2025, the EU's Packaging and Packaging Waste Regulation greatly improved the regulations surrounding the sustainability of packaging. It is predicted that in the next 3 to 5 years, polyglycolic acid may be used in specialty and niche packaging applications due to its rapid biodegradation combined with excellent barrier properties.
• Polymer Technology Improvements: Recent advancements in copolymerization, controlled molecular weight, additives, and processing are advancing Polyglycolic Acid (PGA) to be more tough, flexible, and shelf stable while being able to be implemented in a variety of biomedical applications. Research on bioresorbable polymers for advanced medical applications all over the world has continued to progress steadily in January 2025. Within the next 3-5 years, better control of formulation should make PGA available for use in implantable devices, controlled release systems, filtration and specialty products.
• Sustainability and Circularity Goals: Owners of brands and product manufacturers are increasingly interested in use of materials that reduce the product's long-term environmental burden. By August 2026, the EU will begin to enforce new regulations on packaging, resulting in higher demand for alternatives that are more sustainable, including recyclable, reusable, and compostable. In the next 3-5 years, product owners will focus on sustainable goals, and funding research will be directed toward polyglycolic acid products.
• Manufacturing and Product Innovations: Increased processability has allowed more polymer products to be made. This includes products made of PGA with diverse shapes and forms, including fibers, films, and components used in the medical field. In March 2025, polymer companies were actively pursuing applications for biodegradable fibers and films in the medical sector. In the next 3-5 years, no barriers will exist in developing products spanning diverse markets including healthcare, packaging, agriculture, and industry.

This market faces challenges of:

• High Cost Production: Polyglycolic acid comes with higher production costs than most traditional plastics. This can be attributed to specialty feedstocks, high level polymerization processes, moisture sensitivity and high demand processing which all increase cost. In April 2025 manufacturers felt cost pressure because of the fluctuating energy and chemical market inputs along the global supply chain. It is expected that in the next 3 to 5 years, if there are no large process, production or feedstock changes, high polyglycolic acid costs will limit its potential in cost sensitive packaging or consumer applications.
• Limited Processing and Performance: While there is good strength and barrier performance, polyglycolic acid is brittle and moisture sensitive and has difficult processing. In June 2025 polymer researchers developed blends and copolymers to improve flexibility and thermal stability. In the next 3 to 5 years significant R&D efforts will likely be needed to overcome the limitations of polyglycolic acid and facilitate its substitution of more established plastics in applications requiring high temperature, long shelf life, repeated stress, and exposure to moisture.
• Regulatory Uncertainty and Inconsistent Supply Chains: Different countries define and certify biodegradability, compostability, medical safety and end-of-life treatments in their own ways. In February 2025 new regulations concerning packaging from the EU increased the complexity and cost for material suppliers and converters. In the next 3 to 5 years there will be a lack of both supply and qualified suppliers, reliance on specialized production, high cost and high uncertainty for market expansion.

There are numerous reasons why the future development of polyglycolic acid will be dominated by the needs of the medical field, sustainability, polymer advances, and the growing demand for biodegradable materials. It has great potential in healthcare, packaging, and high-tech industrial applications due to its excellent degradation profile and sophisticated performance. There are numerous challenges to polyglycolic acid's commercialization including high costs, limited processing, differences in regulations from one region to the next, and limited supply. The next three to five years will decide how much polyglycolic acid competes with traditional polymers. The focus will be on fully funded scalable manufacturing, formulations, lifecycle validations, and quicker certifications. During this time, it will be able to penetrate high value markets where performance and biodegradability justify the higher selling price.

List of Polyglycolic Acid Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies polyglycolic acid market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the polyglycolic acid market companies profiled in this report include-

• Kureha
• Corbion
• BMG
• Evonik
• Teleflex
• Samyang Biopharm
• Meta Biomed
• Shanghai Pujing Chemical
• Shenzhen Polymtek Biomaterial
• Huizhou Foryou Medical Device

Polyglycolic Acid Market by Segment

The study includes a forecast for the global polyglycolic acid market by type, application, and region.

Polyglycolic Acid Market by Type [Value ($B) from 2019 to 2035]:

• Industrial Grade
• Medical Grade

Polyglycolic Acid Market by Application [Value ($B) from 2019 to 2035]:

• Oil & Gas
• Medical
• Packing
• Others

Polyglycolic Acid Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Polyglycolic Acid Market

Activity and subsequent demand within the polyglycolic acid market is being driven by regulated medical applications, degradable materials policy, and local resin supply. Between 2025 and 2027, migration to specialty grades is being initiated by market participants. Simultaneously, more governments enact stricter policies for packaging. In Lucintel's latest assessment, these actions drive investments, but do not eradicate the demands for traditional polymers.

• United States: In January 2025, the FDA's medical-device framework continued to support the use of absorbable PGA as sutures, mesh, and drug delivery systems via the 510(k) pathway, while US companies continued to develop bioresorbable implants. This regulatory support is expected to sustain demand for PGA over the next five years by removing the uncertainties of the manufacturing of medical devices and medical implants.
• China: In March 2025, the Chinese National Health Commission continued to procure and register absorbable surgical products, while Chinese polymers and compounders continued to produce bioresorbable polymers and resins. Along with medical-device substitution and manufacturing, China is expected to strengthen its position as a PGA processor and supplier of finished goods in the next five years.
• Germany: In February 2025, the implementation of EU directives regarding packaging waste continued and so did the German investment in certified biodegradable materials and recycling. Although PGA continues to be a medical and a predominately an industrial polymer, stronger regulations will offer opportunities for the production of grades of PGA designed for specific applications, and for collaboration between resin producers and converters in the next five years.
• India: April 2025, actions to advance the strategy on sustainable polymers by the Department of Chemicals and Petrochemicals continued. Meanwhile, hospitals and device manufacturers boosted their use of surgical products that absorb. With the expected policy and procurement influences, this should stimulate domestic conversions, import substitutions, and technology collaboration in PGA-based medical devices up to 2030.
• Japan: In June 2025, Kureha continued shipments of Kuredux PGA resin for use in absorbable medical devices and oil and gas applications from its Japanese operations. Kureha retains significant activity in the major dedicated PGA production capacity attracting customer focus for the advancement of ongoing high purity PGA evaluations.

Features of the Global Polyglycolic Acid Market

• Market Size Estimates: polyglycolic acid market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: polyglycolic acid market size by type, application, and region in terms of value ($B).
• Regional Analysis: polyglycolic acid market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the polyglycolic acid market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the polyglycolic acid market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the polyglycolic acid market by type (industrial grade and medical grade), application (oil & gas, medical, packing, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 6 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Polyglycolic Acid Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Industrial Grade: Trends and Forecast (2019-2035)
• 4.4 Medical Grade: Trends and Forecast (2019-2035)

5. Global Polyglycolic Acid Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Oil & Gas: Trends and Forecast (2019-2035)
• 5.4 Medical: Trends and Forecast (2019-2035)
• 5.5 Packing: Trends and Forecast (2019-2035)
• 5.6 Others: Trends and Forecast (2019-2035)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Polyglycolic Acid Market by Region

7. North American Polyglycolic Acid Market

• 7.1 Overview
• 7.2 North American Polyglycolic Acid Market by Type
• 7.3 North American Polyglycolic Acid Market by Application
• 7.4 United States Polyglycolic Acid Market
• 7.5 Mexican Polyglycolic Acid Market
• 7.6 Canadian Polyglycolic Acid Market

8. European Polyglycolic Acid Market

• 8.1 Overview
• 8.2 European Polyglycolic Acid Market by Type
• 8.3 European Polyglycolic Acid Market by Application
• 8.4 German Polyglycolic Acid Market
• 8.5 French Polyglycolic Acid Market
• 8.6 Spanish Polyglycolic Acid Market
• 8.7 Italian Polyglycolic Acid Market
• 8.8 United Kingdom Polyglycolic Acid Market

9. APAC Polyglycolic Acid Market

• 9.1 Overview
• 9.2 APAC Polyglycolic Acid Market by Type
• 9.3 APAC Polyglycolic Acid Market by Application
• 9.4 Japanese Polyglycolic Acid Market
• 9.5 Indian Polyglycolic Acid Market
• 9.6 Chinese Polyglycolic Acid Market
• 9.7 South Korean Polyglycolic Acid Market
• 9.8 Indonesian Polyglycolic Acid Market

10. ROW Polyglycolic Acid Market

• 10.1 Overview
• 10.2 ROW Polyglycolic Acid Market by Type
• 10.3 ROW Polyglycolic Acid Market by Application
• 10.4 Middle Eastern Polyglycolic Acid Market
• 10.5 South American Polyglycolic Acid Market
• 10.6 African Polyglycolic Acid Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Polyglycolic Acid Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Kureha
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Corbion
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 BMG
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Evonik
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Teleflex
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Samyang Biopharm
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Meta Biomed
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Shanghai Pujing Chemical
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Shenzhen Polymtek Biomaterial
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Huizhou Foryou Medical Device
  • Company Overview
  • Polyglycolic Acid Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us